Cargando…

Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)

A 65-year-old female presented with visual disturbance in her right eye lasting for over 2 months. Following investigations, she was diagnosed with MacTel type 1 in the right eye. Visual symptoms were refractory to initial treatment with intravitreal bevacizumab and thereafter intravtireal triamicin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loutfi, Mohamed, Papathomas, Thomas, Kamal, Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086376/ https://www.ncbi.nlm.nih.gov/pubmed/25045562 http://dx.doi.org/10.1155/2014/231913

Ejemplares similares

Intravitreal Dexamethasone Implant (Ozurdex) for Refractory Macular Edema Secondary to Retinitis Pigmentosa
por: Örnek, Nurgül, et al.
Publicado: (2016)

Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema
por: Pacella, Elena, et al.
Publicado: (2013)

Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
por: Shibeeb, O'Sam, et al.
Publicado: (2014)

Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
por: Castro-Navarro, Verónica, et al.
Publicado: (2019)

Dexamethasone Intravitreal Implant (Ozurdex) for Long-Term Macular Edema after Epiretinal Membrane Peeling Surgery
por: Chang, Yo-Chen, et al.
Publicado: (2018)

Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema
por: Furino, Claudio, et al.
Publicado: (2017)

Intravitreal Dexamethasone Implant (Ozurdex) in Coats’ Disease
por: Saatci, Ali Osman, et al.
Publicado: (2013)

Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
por: Majumder, Parthopratim Dutta, et al.
Publicado: (2016)

Evaluation of the Effect of Intravitreal Dexamethasone (Ozurdex(®)) Implant on Intraocular Pressure in Vitrectomized and Non-Vitrectomized Eyes with Macular Edema
por: Garlı, Murat, et al.
Publicado: (2021)

Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia
por: Aydoğan, Tuğba, et al.
Publicado: (2016)

Change in choroidal volume after dexamethasone intravitreal implant in eyes with diabetic macular oedema
por: Posch‐Pertl, Laura, et al.
Publicado: (2018)

Fractured dexamethasone implant (OZURDEX®) following intravitreal injection
por: Aljohani, Saud M., et al.
Publicado: (2021)

Short-term results of intravitreal dexamethasone implant (OZURDEX(®)) in treatment of recalcitrant diabetic macular edema: A case series
por: Rishi, Pukhraj, et al.
Publicado: (2012)

Results of intravitreal dexamethasone implant (Ozurdex(®)) for retinal vascular diseases with macular edema: An observational study of real-life situations
por: Jirarattanasopa, Pichai, et al.
Publicado: (2022)

Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema
por: Abdel-Hay, Ahmed, et al.
Publicado: (2018)

Spectral domain optical coherence tomography changes following intravitreal dexamethasone implant, Ozurdex(®) in patients with uveitic cystoid macular edema
por: Bansal, Pooja, et al.
Publicado: (2015)

A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)
por: Eris, Erdem, et al.
Publicado: (2017)

Five-Month Observation of Persistent Diabetic Macular Edema after Intravitreal Injection of Ozurdex Implant
por: Zalewski, Dominik, et al.
Publicado: (2014)

Multimodal Imaging Findings and Treatment with Dexamethasone Implant in Three Cases of Idiopathic Macular Telangiectasia Type 1
por: Cirafici, Paola, et al.
Publicado: (2021)

Dexamethasone intravitreal implant in treatment-naïve diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX study
por: Fraser-Bell, Samantha, et al.
Publicado: (2023)

Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: the AUSSIEDEX study
por: Mitchell, Paul, et al.
Publicado: (2023)

Morphology and Function over a One-Year Follow Up Period after Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema
por: Mastropasqua, Rodolfo, et al.
Publicado: (2015)

Intravitreal Injection of Ozurdex(®) Implant in Patients with Persistent Diabetic Macular Edema, with Six-Month Follow-Up
por: Pacella, Fernanda, et al.
Publicado: (2016)

Modified insertion technique for a sustained-release dexamethasone intravitreal implant (Ozurdex®)
por: Lee, Daniel H., et al.
Publicado: (2020)

Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex(®) Outcomes
por: Udaondo, Patricia, et al.
Publicado: (2021)

Real Life Experience of Dexamethasone Implant in Refractory Diabetic Macular Oedema
por: Karttunen, Tommi, et al.
Publicado: (2019)

Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel, Pravin U, et al.
Publicado: (2015)

Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
por: Mishra, S. K., et al.
Publicado: (2018)

Aqueous humour cytokine changes during a loading phase of intravitreal ranibizumab or dexamethasone implant in diabetic macular oedema
por: Podkowinski, Dominika, et al.
Publicado: (2019)

Healthcare expenditure of intravitreal anti‐vascular endothelial growth factor inhibitors compared with dexamethasone implant for diabetic macular oedema
por: Hertzberg, Silvia NW, et al.
Publicado: (2022)

Management of Idiopathic Macular Telangiectasia Type 2
por: Khodabande, Alireza, et al.
Publicado: (2019)

Idiopathic Macular Telangiectasia Type 1 with Ruptured Retinal Arterial Macroaneurysm Post Intravitreal Bevacizumab
por: Nakhwa, Chinmay P., et al.
Publicado: (2015)

PROLONGED OZURDEX-MACULAR CONTACT FOLLOWING VITRECTOMY FOR MACULAR HOLE
por: Kelkar, Aditya S., et al.
Publicado: (2019)

Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser
por: Gale, Richard, et al.
Publicado: (2021)

Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex(®)) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion
por: Chan, Annie, et al.
Publicado: (2011)

Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review
por: Ahn, Seong Joon, et al.
Publicado: (2018)

Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials
por: Danis, Ronald P, et al.
Publicado: (2016)

Intravitreal Dexamethasone Implant (IDI) Alone and Combined with Navigated 577 nm Subthreshold Micropulse Laser (SML) for Diabetic Macular Oedema
por: Toto, Lisa, et al.
Publicado: (2022)

Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment
por: Garweg, Justus G., et al.
Publicado: (2016)

Can the dexamethasone intravitreal implant Ozurdex be safely administered in an out-of-operating room setting?
por: Cidad-Betegón, María del Pino, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_en4v8erf5j66djiqtmqpng28do